VMG is a specialized manufacturer of surgical products with a strong focus on innovation in the surgical field. VMG is known for its CDMO expertise, as well as complete product platforms in Blood collection & Lab sample handling, Injectable drug delivery and Diabetes, besides Sutures. The transaction represents an important milestone in the development of the Group’s CHIRMAX Surgical business unit and supports its long-term strategy focused on combining organic growth with targeted strategic partnerships.